Skip to main content
Clinical Trials/NCT03765840
NCT03765840UnknownNot Applicable

Relationship Between Postoperative Cognitive Decline and Cytokines in Elderly Patients

Jia-feng Wang1 site in 1 country300 target enrollmentStarted: May 1, 2018Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Sponsor
Enrollment
300
Locations
1
Primary Endpoint
Differences in cytokines levels between the two groups

Study Overview

Brief Summary

postoperative cognitive decline is a common and deleterious complication in aged patients.The link between inflammation and postoperative cognitive decline has also been reported.However,the link between SOD1,SOD2,Osteopontin, Kallikrein-6,and Contactin-1 and postoperative cognitive decline is unknown. In this project ,investigators examine the relationship between 5 cytokines measured at there timepoints (preoperative [PREOP], postoperative day 1 [POD1] , and postoperative day 3[POD2]) and postoperative cognitive decline among older adults undergoing orthopedic surgery.

Study Design

Study Type
Observational
Observational Model
Case Control
Time Perspective
Prospective

Eligibility Criteria

Ages
65 Years to 85 Years (Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • patients who are more than 65 years old
  • patients who undergo orthopedic surgery(trauma ,especially fracture of lower limb)
  • patients with ASA physical status I-III
  • patients who have a consent

Exclusion Criteria

  • patients who are more than 85 years old
  • patients with ASA physical status >III
  • patients who have neurological disorders, stroke or other affective central nervous system diseases
  • patients who have a history of serious psychiatric illness
  • patients with long-term use of psychoactive substances
  • patients who undergo multiple trauma and the presence of head injury

Outcomes

Primary Outcomes

Differences in cytokines levels between the two groups

Time Frame: 72h after operation

Compare differences in cytokines levels between the two groups

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Jia-feng Wang
Sponsor Class
Other
Responsible Party
Sponsor Investigator
Principal Investigator

Jia-feng Wang

M.D

Changhai Hospital

Study Sites (1)

Loading locations...

Similar Trials